HIGHLIGHTS
- who: Bong-Geum Jang and colleagues from the Institute of Epilepsy Research, College of Medicine, Hallym University, Chuncheon, Korea have published the research: 2,4-Diacetylphloroglucinol Reduces Beta-Amyloid Production and Secretion by Regulating ADAM10 and Intracellular Trafficking in Cellular and Animal Models of Alzheimer’s Disease, in the Journal: Cells 2022, 2585 of /2022/
- what: Although 3 of 24 DAPG might not cross the blood-brain barrier (BBB), this study shows the potential of DAPG or derivatives as therapeutic components against AD. This study shows that DAPG, a low-molecular-weight phloroglucinol derivative, decreased . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.